Unlock instant, AI-driven research and patent intelligence for your innovation.

Macrolide compound

a macrolide compound and compound technology, applied in the field of new macrolide compound, can solve the problems of constant development of anticancer agents, and achieve the effect of excellent proliferation inhibition

Inactive Publication Date: 2011-12-06
HOKKAIDO UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The macrolide compound demonstrates excellent proliferation-inhibiting effects against human tumor cells, offering a novel anticancer agent with potential for effective treatment with minimal side effects and resistance issues.

Problems solved by technology

Amid a growing demand for such new anticancer agents, anticancer agent development is constantly required due to such problems as side effects of an anticancer agent, generation of drug-resistant cancer cells caused by long-term use of anticancer agents and different medicinal effects by the type of cancer.
Because of the above-mentioned problems, however, seeking and development of anticancer agents, marine organism-derived antitumor substances in particular, is always regarded as a crucially important issue.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Macrolide compound
  • Macrolide compound
  • Macrolide compound

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0046]A seawater-fortified nutrient having compositions as shown in the above Table 1 was added to seawater autoclave-sterilized at 120° C. for 20 minutes so as to set the concentration at 1%. Then, after 3 mM NaHCO3 was added thereto with a pH ranging from 7.3 to 8.5, dinoflagellate alga Strains HYA002 and / or HYA024 were inoculated in a culture solution prepared by filter sterilization using a filter with a pore diameter of 0.22 μm. The product was allowed to stand for culturing at 25° C. for approx. 14 days, irradiated with 3000 lux light during one cycle, composed of 16 hours in light time period and 8 hours in dark time period.

[0047]Subsequently, 200 mL of methanol / toluene (3:1) was added to 60.5 g of dinoflagellate alga collected by centrifugal separation and the product was agitated (3 times). Thereafter, 100 mL of 1M NaCl was added thereto and culture algae were extracted with 100 mL of toluene 3 times. All toluene fractions (730 mg) were put in a silica gel column (eluate: C...

example 2

[0056]Human BuRkitt's lymphoma cell line (DG-75, ATCC No. CRL-2675) or human Burkitt's lymphoma cell line (Raji, ATCC No. CRL-86) was suspended in an RPMI-1640 medium (SIGMA) (hereinafter called culture solution) containing 10% calf serum (Moregate) and 10% fetal bovine serum (Hyclone) so as to set the cell number at 1×105 / mL. After 50 μL of the cell suspension was added to a 96-well microplate, 49 μL of the above culture solution was added thereto to set the whole volume at 99 μL. Compounds represented by Formulae (6) to (11) that solved in DMSO, 5-FU (Wako) or doxorubicin (Wako) (all 0.0001 to 10 μg / mL) were each added to one well by 1 μL, and cultured with a CO2 concentration of 5% at 37° C. for 72 hours. After culturing, 10 μL of Wako cell Counting Kit-8 (Wako) was added to each well and subjected to color reaction in a CO2 incubator for 3 hours. Proliferation-inhibition rate was calculated from absorbance values measured with a microplate reader at 450 nm (reference wavelength:...

example 3

[0059]A compound represented by Formula (8) (50 to 500 μg / kg) that solved in ethanol or 5-FU (10 mg / kg) was administered to an 8-week old female Balb / c mouse (Japan SLC) having approx. 1×105 of Meth A fibrosarcoma cells (Kitasato Institute) intraperitoneally transplanted therein by ⅓ of the whole volume at 7th, 9th and 11th days intravenously (but 5-FU administered intraperitoneally) to measure tumor weight at 21st day. Using a control mouse to which normal saline solution was administered in lieu of a test compound, anticancer activity on each compound was expressed in number according to a formula of proliferation-inhibition rate (%)=(1−(sample / blank))×100. Table 3 shows the results.

[0060]

TABLE 3Concentration (μg / kg)Proliferation-inhihition rate (%)Formula (8)505.320062.250054.35-FU1000060.2

[0061]The above test found that the compound represented by Formula (8) shows almost the same proliferation-inhibition rate (anticancer activity) as 5-FU even when it is administered with a low...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore diameteraaaaaaaaaa
flow rateaaaaaaaaaa
volumeaaaaaaaaaa
Login to View More

Abstract

Disclosed are: a novel dinoflagellate alga; and a macrolide compound which can be used as a novel anticancer agent. Specifically disclosed is a macrolide compound produced by a dinoflagellate Amphidinium sp. Strain HYA002 or HYA0024. The macrolide compound has excellent proliferation-inhibiting effect against a human tumor cell and therefore can be used as a novel anticancer agent.

Description

TECHNICAL FIELD[0001]The present invention relates to a novel macrolide compound, an anticancer agent with the macrolide compound as an active ingredient and a method for producing the macrolide compound. This invention pertains to a patent application regarding the results of an entrusted research by the Japan's national government and other organizations (effective promotion of a joint research by industrial, academic and government sectors, “Miriyobisaimo karano yuyokagakusozai no tansaku to kaihatsu (Seeking and development of useful chemical materials from unused microalgae)” financed by 2006 Special Coordination Funds for the Promotion of Science and Technology sponsored by the Ministry of Education, Culture, Sports, Science and Technology in compliance with Article 30 of the Act on Special Measures concerning Industrial Revitalization).BACKGROUND ART[0002]A variety of compounds constituting anticancer agents are currently developed by examining a derivation and a chemical str...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(United States)
IPC IPC(8): C07D321/00C07D493/00C07D313/04
CPCC07D313/00C07D315/00C07D493/04C07D493/08C07D493/18C12P17/08A61P35/00
Inventor TSUDA, MASASHIOGUCHI, KEIKOIWAMOTO, RIEOKAMOTO, YUMIKO
Owner HOKKAIDO UNIVERSITY